Gloria Reeves - Publications

Affiliations: 
University of Maryland School of Medicine, Baltimore, MD, United States 

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Akouri-Shan L, Schiffman J, Millman ZB, Demro C, Fitzgerald J, Rakhshan Rouhakhtar PJ, Redman S, Reeves GM, Chen S, Gold JM, Martin EA, Corcoran C, Roiser JP, Buchanan RW, Rowland LM, et al. Relations Among Anhedonia, Reinforcement Learning, and Global Functioning in Help-seeking Youth. Schizophrenia Bulletin. PMID 34240217 DOI: 10.1093/schbul/sbab075  0.611
2019 Millman ZB, Gallagher K, Demro C, Schiffman J, Reeves GM, Gold JM, Rakhshan Rouhakhtar PJ, Fitzgerald J, Andorko ND, Redman S, Buchanan RW, Rowland LM, Waltz JA. Evidence of reward system dysfunction in youth at clinical high-risk for psychosis from two event-related fMRI paradigms. Schizophrenia Research. PMID 30995969 DOI: 10.1016/J.Schres.2019.03.017  0.597
2018 Ross M, Nguyen V, Bridges JFP, Ng X, Reeves G, Frosch E, dosReis S. Caregivers' Priorities and Observed Outcomes of Attention-Deficit Hyperactivity Disorder Medication for Their Children. Journal of Developmental and Behavioral Pediatrics : Jdbp. 39: 93-100. PMID 29461996 DOI: 10.1097/Dbp.0000000000000530  0.374
2018 Waltz J, Demro C, Millman Z, Reeves G, Roiser J, Gold J, Schiffman J. 26.3 SALIENCE SIGNALING AND THE EMERGENCE OF PSYCHOPATHOLOGY IN YOUTH AT CLINICAL HIGH RISK FOR PSYCHOTIC ILLNESS Schizophrenia Bulletin. 44: S43-S43. DOI: 10.1093/Schbul/Sby014.108  0.522
2017 Demro C, Rowland L, Wijtenburg SA, Waltz J, Gold J, Kline E, Thompson E, Reeves G, Hong LE, Schiffman J. Glutamatergic metabolites among adolescents at risk for psychosis. Psychiatry Research. 257: 179-185. PMID 28772136 DOI: 10.1016/J.Psychres.2017.07.040  0.571
2016 dosReis S, Park A, Ng X, Frosch E, Reeves G, Cunningham C, Janssen EM, Bridges JF. Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis. Journal of Child and Adolescent Psychopharmacology. PMID 27991834 DOI: 10.1089/Cap.2016.0157  0.406
2016 Ng X, Bridges JF, Ross MM, Frosch E, Reeves G, Cunningham CE, dosReis S. A Latent Class Analysis to Identify Variation in Caregivers' Preferences for their Child's Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment? The Patient. PMID 27798814 DOI: 10.1007/S40271-016-0202-Z  0.338
2016 Ross M, Kim H, Bridges J, Ng X, Frosch E, Reeves G, dosReis S. Initiating Medication To Treat Pediatric Attention-Deficit/Hyperactivity Disorder: A Best-Worst Scaling To Compare Caregivers’ And Clinicians’ Preferences Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1337  0.355
2016 dosReis S, Ng X, Ross M, Frosch E, Reeves G, Bridges J. Preferences For Pediatric Attention-Deficit/Hyperactivity Disorder Management And Medication Changes And Caregiver-Reported Improvement Over A 6-Month Follow-Up Value in Health. 19. DOI: 10.1016/J.Jval.2016.03.1335  0.325
2015 Waltz JA, Demro C, Schiffman J, Thompson E, Kline E, Reeves G, Xu Z, Gold J. Reinforcement Learning Performance and Risk for Psychosis in Youth. The Journal of Nervous and Mental Disease. PMID 26588080 DOI: 10.1097/Nmd.0000000000000420  0.589
2015 Ross M, Bridges JF, Ng X, Wagner LD, Frosch E, Reeves G, dosReis S. A best-worst scaling experiment to prioritize caregiver concerns about ADHD medication for children. Psychiatric Services (Washington, D.C.). 66: 208-11. PMID 25642618 DOI: 10.1176/Appi.Ps.201300525  0.332
2015 Ng X, Bridges JF, Ross MM, Frosch EJ, Reeves GM, dosReis S. Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD): a latent class analysis Value in Health. 18. DOI: 10.1016/J.Jval.2015.03.717  0.409
2012 Schweitzer JB, Fassbender C, Lit L, Reeves GM, Powell SP. Attention-deficit/hyperactivity disorder. Handbook of Clinical Neurology. 106: 391-405. PMID 22608633 DOI: 10.1016/B978-0-444-52002-9.00022-X  0.651
2011 Fassbender C, Schweitzer JB, Cortes CR, Tagamets MA, Windsor TA, Reeves GM, Gullapalli R. Working memory in attention deficit/hyperactivity disorder is characterized by a lack of specialization of brain function. Plos One. 6: e27240. PMID 22102882 DOI: 10.1371/Journal.Pone.0027240  0.633
2004 Reeves G, Schweitzer J. Pharmacological management of attention-deficit hyperactivity disorder. Expert Opinion On Pharmacotherapy. 5: 1313-20. PMID 15163276 DOI: 10.1517/14656566.5.6.1313  0.64
Show low-probability matches.